CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $83.07 ($249,215)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $80.03 ($160,051)
- 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $74.92 ($153,586)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $80.11 ($240,333)
- 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $84.58 ($173,389)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $86.76 ($173,512)
- 4 Open-market sale Principal Accounting Officer sold 272 shares at $84.94 ($23,104)
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $83.50 ($250,503)
- 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $97.58 ($200,039)
- 4 Open-market sale Director sold 9,000 shares at an average $93.55 ($841,926)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $92.89 ($185,786)
Page 20 of 38 · 758 filings